Pembrolizumab Monoclonal Antibody from China
Pembrolizumab is a humanized IgG4 monoclonal antibody that blocks PD-1 and is used in immunotherapy for melanoma and lung cancer. This bulk, unmixed product is not put up in measured doses or retail packaging, qualifying it for tariff item 3002.13.00.
Duty Rate — China → Canada
0%
Import Tips
• Ensure the product is imported as a pure, unmixed substance without any additives
• Keep detailed documentation of the biotechnological production process for CBSA review
• Check whether a Drug Submission or Clinical Trial Application is required for the intended use